FDA Radiology AI Devices

The Riptide Aspiration System is a medical device designed to restore blood flow in patients suffering from acute ischemic stroke caused by intracranial large vessel occlusions. It uses continuous aspiration via specialized catheters and pumping system to remove blood clots from critical arteries in the brain, helping clinicians quickly reopen blocked vessels and potentially improve patient outcomes.

The CEREGLIDE 42 and 57 Intermediate Catheters, together with the Cerenovus Aspiration Tubing Set, are medical devices used to remove blood clots from large intracranial vessels during acute ischemic strokes. These catheters are navigated through the brain's blood vessels under fluoroscopic imaging to restore blood flow by aspirating clots, helping patients who cannot receive or have failed drug-based clot dissolving treatments.

BrainSee is software that helps clinicians predict whether patients aged 55 to 95 with amnestic mild cognitive impairment (aMCI) will progress to clinical Alzheimer's disease dementia within 5 years. It uses standard brain MRI scans along with patient demographics and cognitive test scores to generate a similarity score indicating the likelihood of progression. This tool provides supplemental prognostic information to aid clinical decision-making but is not a standalone diagnostic device.

The REMI AI Discrete Detection Module (REMI-AI DDM) is a software tool designed to assist physicians qualified in EEG interpretation by automatically identifying and marking sections of EEG recordings that may correspond to seizure-like events. It processes previously acquired EEG data collected via the REMI Remote EEG Monitoring System, helping speed up and improve the review process for EEG data in patients aged 6 years and older. The software does not provide diagnostic conclusions but serves as an aid to clinicians in seizure detection support.

EyeBOX is an eye-tracking device designed to help diagnose concussion by measuring and analyzing eye movements in patients within one week of a head injury. It uses near-infrared cameras to track gaze positions and an AI-driven algorithm to detect subtle changes in eye movements associated with concussion, aiding clinicians in neurological assessment.